Matt Frevel
Directeur des opérations chez Migco Pharmaceuticals Ltd.
Profil
Matt Frevel is currently the Chief Operating Officer at Migco Pharmaceuticals Ltd.
and the Chief Scientific Officer at Enzo Nutraceuticals Ltd.
He holds a doctorate degree from the University of Otago and an undergraduate degree from the University of Bonn.
Postes actifs de Matt Frevel
| Sociétés | Poste | Début |
|---|---|---|
Migco Pharmaceuticals Ltd.
 Migco Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Migco Pharmaceuticals Ltd. develops new drug therapeutic products. The firm is focused on developing new drug therapies for the prevention and treatment of migraine headaches. It has clinical safety data for its lead compound MGX-008. The company was founded by Larry Ellsworth Stenswick in 2004 and is headquartered in Rangiora, New Zealand. | Directeur des opérations | - |
| Enzo Nutraceuticals Ltd. | Directeur Technique/Scientifique/R&D | - |
Formation de Matt Frevel
| University of Bonn | Undergraduate Degree |
| University of Otago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Migco Pharmaceuticals Ltd.
Migco Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Migco Pharmaceuticals Ltd. develops new drug therapeutic products. The firm is focused on developing new drug therapies for the prevention and treatment of migraine headaches. It has clinical safety data for its lead compound MGX-008. The company was founded by Larry Ellsworth Stenswick in 2004 and is headquartered in Rangiora, New Zealand. | Health Technology |
| Enzo Nutraceuticals Ltd. |
